A national ABCD study finds early heavy social media use tied to much higher odds that teens will try alcohol, nicotine and cannabis.

Unregulated injectable peptides marketed online are rising among teens and young men in DC, prompting warnings from doctors and federal regulators. Clinicians and the FDA say the risks go beyond marketing claims.

Certain duloxetine (generic Cymbalta) lots were recalled after tests found a nitrosamine impurity; regulators and pharmacists advise checking NDCs and talking to your prescriber.

A biomarker analysis of more than 30,000 adults found that most people who meet the 'five-a-day' guideline still fall short of the 500 mg/day flavanol level linked to lower heart deaths.

MedStar will close one postpartum unit at Washington Hospital Center, cutting 11 beds and displacing staff as the system cites financial pressures while union and community leaders push back.

The FDA added bemotrizinol to the U.S. sunscreen monograph, the first new active allowed since the 1990s; DSM gets limited exclusivity and products are expected later this year.

A new federally commissioned study finds health risks rise after one drink a day and recommends one drink or fewer, while the 202520130 Dietary Guidelines omitted numeric limits.

Cigna will end coverage of GLP‑1 weight‑loss medications for employees on July 1, pushing staff toward cash payments and manufacturer or federal discount programs. The move follows price shifts driven by new oral pills and the Medicare Bridge.

Target recalled select Up & Up baby wipes after lab tests found Burkholderia bacteria. Parents should check pack codes and stop using affected wipes.

A new PNAS analysis finds cohorts born after 1970 are dying at higher rates and a post‑2010 downturn may stall U.S. life‑expectancy gains.

Federal officials added Hawaii to a ten‑state Medicaid demonstration to expand mental‑health and addiction care. Maui clinics are slated for early certification.

A national firefighter cancer registry is growing quickly, but Nevada signups lag. Local experts say bigger enrollment is needed to link southern Nevada exposures to long‑term risk.

A CDC review of consultations from 2014–2024 links about 145 U.S. patients to post‑op infections and four deaths after cosmetic surgery travel, prompting calls for stronger monitoring and patient guidance.